Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic Treatment

Autosomal recessive and autosomal dominant polycystic kidney disease (ARPKD, ADPKD) are systemic disorders with pronounced hepatorenal phenotypes. While the main underlying genetic causes of both ARPKD and ADPKD have been well-known for years, the exact molecular mechanisms resulting in the observed...

Descripción completa

Detalles Bibliográficos
Autores principales: Haumann, Sophie, Müller, Roman-Ulrich, Liebau, Max C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503958/
https://www.ncbi.nlm.nih.gov/pubmed/32847032
http://dx.doi.org/10.3390/ijms21176093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503958/
https://www.ncbi.nlm.nih.gov/pubmed/32847032
http://dx.doi.org/10.3390/ijms21176093

Ejemplares similares